• Rakuten Medical reels in another megaround to fund cancer R&D fiercepharma
    August 13, 2019
    Rakuten Medical has raised $100 million to advance its pipeline of photoimmunotherapy oncology prospects. The biotech hopes to use antibodies and light to destroy cancer cells while leaving healthy tissues unharmed. 
PharmaSources Customer Service